NCT02172846View on ClinicalTrials.gov

Hypofractionated Proton Beam Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Stage II-III Non-Small Cell Lung Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

May 22, 2014

Primary Completion Date

August 23, 2016

Study Completion Date

October 2, 2017

Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
RADIATION

Proton beam radiation therapy (PBT)

DRUG

Paclitaxel

DRUG

Carboplatin

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT02172846 - Hypofractionated Proton Beam Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Stage II-III Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter